Distinct roles of JNKs/p38 MAP kinase and ERKs in apoptosis and survival of HCD-57 cells induced by withdrawal or addition of erythropoietin

Blood

Volumn 94, Issue 12, 1999, Pages 4067-4076

  Shan, Rujiao ^a   Price, James O ^a   Gaarde, William A ^a   Monia, Brett P ^a   Krantz, Sanford B ^a   Zhao, Zhizhuang Joe ^a  

^a MRB II ^*

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ERYTHROPOIETIN; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 12 ACETATE 13 MYRISTATE; RECOMBINANT ERYTHROPOIETIN; SYNAPTOPHYSIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ERYTHROID CELL; ERYTHROPOIESIS; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0032762406     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.12.4067     Document Type: Article

References (42)

1. Krantz SB: Erythropoietin. Blood 77:419, 1991
2. Ogawa M: Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844, 1993
3. Koury MJ, Bondurant MC: Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 248:378, 1990
4. Spivak JL, Pham T, Isaacs M, Hankins WD: Erythropoietin is both a mitogen and survival factor. Blood 77:1228, 1991
5. Klingmuller U: The role of tyrosine phosphorylation in proliferation and maturation of erythroid progenitor cells - Signals emanating from the erythropoietin receptor. Eur J Biochem 249:637, 1997
6. Seger R, Krebs EG: The MAPK signaling cascade. FASEB J 9:726, 1995
7. Lewis TS, Shapiro PS, Ahn NG: Signal transduction through MAP kinase cascades. Adv Cancer Res 74:49, 1998
8. Kyriakis JM, Avruch J: Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays 18:567, 1996
9. Paul A, Wilson S, Belham CM, Robinson CJ, Scott PH, Gould GW, Plevin R: Stress-activated protein kinases: Activation, regulation and function. Cell Signal 9:403, 1997
10. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326, 1995
11. Zhao Z, Tan T, Wright JH, Diltz CD, Shen S-H, Krebs EG, Fischer EH: Altered expression of protein tyrosine phosphatase 2C in 293 cells affects protein tyrosine phosphorylation and MAP kinase activation. J Biol Chem 270:11765, 1995
12. Sawada K, Krantz SB, Kans JS, Dessypris EN, Sawyer S, Glick AD, Civin Cl: Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin. J Clin Invest 80:357, 1987
13. Monia BP: First- and second-generation antisense inhibitors targeted to human c-raf kinase: In vitro and in vivo studies. Anticancer Drug Des 12:327, 1997
14. Miura Y, Miura O, Ihle JN, Aoki N: Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor. J Biol Chem 269:29962, 1994
15. Verdier F, Chrétien S, Billat C, Gisselbrecht S, Lacombe C, Mayeux P: Erythropoietin induces the tyrosine phosphorylation of insulin receptor substrate-2. An alternate pathway for erythropoietin-induced phosphatidylinositol 3-kinase activation. J Biol Chem 272: 26173, 1997
16. Klingmuller U, Wu H, Hsiao JG, Toker A, Duckworth BC, Cantley LC, Lodish HF: Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Poc Natl Acad Sci USA 94:3016, 1997
17. Barber DL, Corless CN, Xia K, Roberts TM, D'Andrea AD: Erythropoietin activates Raf1 by an She-independent pathway in CTLL-EPO-R cells. Blood 89:55, 1997
18. Sui X, Krantz SB, You M, Zhao Z: Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis. Blood 92:1142, 1998
19. Nagata Y, Nishida E, Todokoro K: Activation of JNK signaling pathway by erythropoietin, thrombopoietin, and interleukin-3. Blood 89:2664, 1997
20. Nagata Y, Takahashi N, Davis RJ, Todokoro T: Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood 92:1859, 1998
21. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, Sturgill TW: Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262:1065, 1993
22. Graves LM, Bornfeldt KE, Raines EW, Potts BC. Macdonald SG, Ross R, Krebs EG: Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Poc Natl Acad Sci USA 90:10300, 1993
23. Waskiewicz AJ, Cooper JA: Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr Opin Cell Biol 7:798, 1995
24. Sun H, Charles CH, Lau LF, Tonks NK: MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75:487, 1993
25. Sun H, Tonks NK: The coordinated action of protein tyrosine phosphatases and kinases in cell signaling. Trends Biochem Sci 19:480, 1994
26. Evan G, Littlewood T: A matter of life and cell death. Science 281:1317, 1998
27. Ashkenazi A, Dixit VM: Death receptors: Signaling and modulation. Science 281:1305, 1998
28. Thornberry NA, Lazebnik Y: Caspases: Enemies within. Science 281:1312, 1998
29. Adams JM, Cory S: The Bcl-2 protein family: Arbiters of cell survival. Science 281:1322, 1998
30. Green DR, Reed JC: Mitochondria and apoptosis. Science 281:1309, 1998
31. Moriyama M, Yamochi T, Semba K, Akiyama T, Mori S: BCL-6 is phosphorylated at multiple sites in its serine- and proline-clustered region by mitogen-activated protein kinase (MAPK) in vivo. Oncogene 14:2465, 1997
32. Horiuchi M, Hayashida W, Kambe T, Yamada T, Dzau VJ: Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J Biol Chem 272:19022, 1997
33. Maundrell K, Antonsson B, Magnenat E, Camps M, Muda M, Chabert C, Gillieron C, Boschert U, Vial-Knecht E, Martinou JC, Arkinstall S: Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1. J Biol Chem 272:25238, 1997
34. Ito T, Deng X, Carr B, May WS: Bcl-2 phosphorylation required for anti-apoptosis function. J Biol Chem 272:11671, 1997
35. L. Cell 87:619, 1996
36. del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G: Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278:687, 1997
37. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231, 1997
38. Cardone MH, Salvesen GS, Widmann C, Johnson G, Frisch SM: The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell 90:315, 1997
39. Graves JD, Gotoh Y, Draves KE, Ambrose D, Han DK, Wright M, Chernoff J, Clark EA, Krebs EG: Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1. EMBO J 17:2224, 1998
40. Wang HG, Rapp UR, Reed JC: Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87:629, 1996
41. Whitmarsh AJ, Davis RJ: Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 74:589, 1996
42. Jacobshelber SM, Wickrema A, Birrer MJ, Sawyer ST: AP1 regulation of proliferation and initiation of apoptosis in erythropoietin-dependent erythroid cells. Mol Cell Biol 18:3699, 1998